The risk of heart infection higher after Covid when compared to incidence post-vaccination

Study finds the risk of myocarditis was substantially higher in the four weeks after COVID-19 infection than after a first dose of a COVID-19 vaccine.
DALLAS -- In a detailed analysis of nearly 43 million people, the risk of myocarditis in unvaccinated individuals after COVID-19 infection was at least 11 times higher compared to people who developed myocarditis after receiving a COVID-19 vaccine or booster dose, according to new research published today in the American Heart Association’s flagship, peer-reviewed journal Circulation. This analysis included data from England’s National Immunization database for people ages 13 and older who received at least one dose of a COVID-19 vaccine between December 1, 2020 and December 15, 2021 in England.

Several previous studies and reports from public health agencies around the world including the U.S. Centers for Disease Control and Prevention have highlighted a possible connection and potentially increased risk of myocarditis after receiving an mRNA COVID-19 vaccine, generating considerable scientific, policy and public interest.

Typically thought to be trigged by a viral infection, myocarditis is the inflammation of the heart muscle, the myocardium. This condition is uncommon and may temporarily or permanently weaken the heart muscle and the heart’s electrical system, which keeps the heart beating normally. An episode of myocarditis may resolve on its own or with treatment, and may result in lasting damage to the heart. In the general population not during a global pandemic, it is estimated that approximately 10 to 20 people per 100,000 are diagnosed with myocarditis each year, according to the American Heart Association’s 2021 scientific statement on myocarditis.

“We found that across this large dataset, the entire COVID-19-vaccinated population of England during an important 12-month period of the pandemic when the COVID-19 vaccines first became available, the risk of myocarditis following COVID-19 vaccination was quite small compared to the risk of myocarditis after COVID-19 infection,” says first author of the study Martina Patone, Ph.D., a statistician at the Nuffield Department of Primary Health Care Sciences at the University of Oxford in Oxford, England. “This analysis provides important information that may help guide public health vaccine campaigns, particularly since COVID-19 vaccination has expanded in many parts of the world to include children as young as 6 months old.”

In this study, Patone and colleagues evaluated England’s National Immunization database of COVID-19 vaccinations for all people ages 13 or older who had received at least one dose of the ChAdOx1 (a two-dose adenovirus-vector COVID-19 vaccine developed by the University of Oxford and AstraZeneca, most similar to the one-dose Johnson & Johnson/Janssen COVID-19 vaccine available in the U.S.), the Pfizer-BioNTech or the Moderna COVID-19 vaccine (the same mRNA vaccines available in the U.S.) between December 1, 2020 and December 15, 2021. This dataset totaled nearly 43 million people, which included more than 21 million who had received a booster dose of any of the COVID-19 vaccines (meaning they had received a total of 3 doses of a COVID-19 vaccine). The database detailed the type of COVID-19 vaccines received, dates received and dose sequencing, along with individual demographic information including age and sex for each individual. Nearly 6 million people tested positive for COVID-19 infection either before or after COVID-19 vaccination during the study period.

England’s National Immunization database records were then cross-referenced and matched to the national offices with data on COVID-19 infection, hospital admission and death certificates for the same time period, December 1, 2020 through December 15, 2021. Individuals were classified based on age and sex to reveal which groups had the highest risk of myocarditis after a COVID-19 vaccine or after COVID-19 infection and hospitalization. The authors used the self-controlled case series (SCCS) method, which was developed to estimate the relative incidence of an acute event in a pre-defined post-vaccination risk period (1-28 days), compared to other times (pre-vaccination or long after vaccination). Being a within-person comparison, the analyses were controlled to adjust for any fixed characteristics, including sex, race or ethnicity, or chronic health conditions.

In the overall dataset of nearly 43 million people, the analyses found:

  • Fewer than 3,000 (n=2,861), or 0.007%, people were hospitalized or died with myocarditis during the one-year study period. 617 of these cases of myocarditis occurred during days 1-28 after receiving a COVID-19 vaccination, of which 514 were hospitalized.
  • People who were infected with COVID-19 before receiving any doses of the COVID-19 vaccines were 11 times more at risk for developing myocarditis during days 1-28 after a COVID-19 positive test.
  • The risk of COVID-19 infection-related myocarditis risk was cut in half among people infected after vaccination (received at least one dose of a COVID-19 vaccine).
  • The risk of myocarditis increased after a first dose of the ChAdOx1 COVID-19 vaccine (an adenovirus-vector vaccine most similar to the Johnson & Johnson/Janssen COVID-19 vaccine available in the U.S.) and after a first, second and booster dose of any of the mRNA COVID-19 vaccines. However, the risk of vaccine-associated myocarditis was lower compared to the risk of COVID-19 infection-associated myocarditis, except for after a second dose of the Moderna vaccine.
  • Myocarditis risk was found to be higher during days 1-28 after a second dose of the Moderna COVID-19 vaccine for people of all genders and ages, and the risk also persisted after a booster dose of the Moderna vaccine. However, people receiving a booster dose of Moderna were, on average, younger in comparison to those who received a booster dose of the ChAdOx1 or Pfizer-BioNTech vaccine, therefore, results may not be generalizable to all adults.
  • Risk of COVID-19 vaccine-associated myocarditis among women:

  • Of the nearly 21 million women, 7.2 million (34%) were younger than age 40, and a slightly increased risk of myocarditis was found among this younger age group after receiving a second dose of the Moderna COVID-19 vaccine: 7 estimated extra cases of myocarditis for every one million women vaccinated.
  • Among women older than age 40, a slight increased risk of myocarditis was associated with receiving a first or third dose of the Pfizer-BioNTech COVID-19 vaccine, respectively 3 and 2 estimated additional cases of myocarditis for every one million women vaccinated.
  • Risk of COVID-19 infection-associated myocarditis among women:

  • Among women younger than age 40, the risk of infection-associated myocarditis was higher compared to the risk of vaccine-associated myocarditis: 8 extra cases associated with having COVID-19 infection before vaccination.
  • Among women older than age 40, the risk of infection-associated myocarditis was higher compared to the risk of vaccine-associated myocarditis: 51 extra cases associated with having COVID-19 infection before vaccination.
  • Risk of COVID-19 vaccine-associated myocarditis among men:

  • Among the 18 million men in the dataset, all of whom received at least one COVID-19 vaccine, more than 6 million men (34%) were younger than age 40.
  • An increased risk of vaccine-associated myocarditis was found in men ages 40 and younger after a first dose of either of the mRNA COVID-19 vaccines (4 and 14 estimated extra cases for every one million men vaccinated with respectively Pfizer or Moderna vaccine), or a second dose of any of the three COVID-19 vaccines available in England during the study period: 14, 11 and 97 estimated additional cases of myocarditis for every one million men vaccinated, respectively for the ChAdOx1, the Pfizer-BioNTech or the Moderna vaccine.
  • The increased risk of developing myocarditis among males younger than age 40 was also higher after receiving two doses of the Moderna vaccine when compared to the risk of myocarditis after COVID-19 infection. The researchers noted, however, the average age of people who received the Moderna vaccine was 32 years, compared to the majority of those who received the other vaccines were older than age 40.
  • In men ages 40 and older, a slightly increased risk of myocarditis was found after a booster dose of either of the two mRNA vaccines (Pfizer-BioNTech or Moderna): 3 estimated extra cases of myocarditis for every one million men vaccinated with either mRNA vaccine.
  • Risk of COVID-19 infection-associated myocarditis among men:

  • Among men younger than age 40, the risk of infection-associated myocarditis was higher compared to the risk of vaccine-associated myocarditis: 16 extra cases associated with having infection before vaccination, with the only exception of a second dose of Moderna vaccine.
  • Among men older than age 40, the risk of infection-associated myocarditis was higher compared to the risk of vaccine-associated myocarditis: 85 extra cases associated with having infection before vaccination.
  • “It is important for the public to understand that myocarditis is rare, and the risk of developing myocarditis after a COVID-19 vaccine is also rare. This risk should be balanced against the benefits of the COVID-19 vaccines in preventing severe COVID-19 infection. It is also crucial to understand who is at a higher risk for myocarditis and which vaccine type is associated with increased myocarditis risk, ” said Professor Nicholas Mills, Ph.D., the Butler British Heart Foundation Chair of Cardiology at the University of Edinburgh and a co-author of the paper. “These findings are valuable to help inform recommendations on the type of COVID-19 vaccines available for younger people and may also help shape public health policy and strategy for COVID-19 vaccine boosters. The SARS-CoV-2 virus continues to shift, and more contagious variants arise; our hope is that this data may enable a more well-informed discussion on the risk of vaccine-associated myocarditis when considered in contrast to the net benefits of COVID-19 vaccination,” said another co-author Julia Hippisley-Cox, F.R.C.P., professor of clinical epidemiology and general practice at the University of Oxford.

    Authors noted there are two unanswered questions that likely require further investigation. The first is about myocarditis risk among children ages 13-17 because there were too few cases of myocarditis to quantify the risk specific to this age group. Secondly, researchers were not able to directly compare the death rate after COVID-19 infection vs. death after COVID-19 vaccination since the database only included people who had received at least one COVID-19 vaccine. More expansive data and a different analysis are still needed to address these questions and numerous other COVID-19 topics.

    The study has two notable limitations. The number of cases of myocarditis among individuals who received a booster dose of the ChAdOx1 or Moderna vaccines was too small to calculate the risk of myocarditis. Additionally, researchers cannot exclude the possibility of over- or under-estimated risk due to misclassification of any health information in the database, though the U.K.’s National Health Service is known to provide timely and accurate data.

    AHA agrees with CDC guidelines, recommends Covid-19 booster

    (Amreican Heart Association) -- As the Omicron variant spreads, COVID-19 vaccination is more important than ever. The American Heart Association continues to align with expert guidance from the U.S. Centers for Disease Control and Prevention (CDC) – the nation’s infectious disease experts - regarding COVID-19 vaccinations and booster shots.

    Recently, the CDC extended recommendations for a booster dose of COVID-19 vaccines to all adults ages 18 and older, including the allowance to "mix & match" the types of COVID-19 vaccines for the booster dose. According to the CDC, the additional COVID-19 vaccine dose may be from any of the three COVID-19 vaccines authorized or approved in the U.S. – either the Pfizer-BioNTech, Moderna or Johnson & Johnson COVID-19 vaccines. The mix & match regimen is available only for booster doses of the COVID-19 vaccines, not for the primary vaccination series, which still requires the same, initial two doses of either the Pfizer-BioNTech or Moderna COVID-19 vaccine.

    The CDC recommends a booster of either the Moderna or Pfizer-BioNTech COVID-19 vaccine (mRNA vaccines) for all adults at least 6 months after receiving two-doses of the same mRNA COVID-19 vaccine. Adults ages 18 and older who previously received one dose of the Johnson & Johnson COVID-19 vaccine (an adenovirus vector vaccine) are eligible for a booster dose two months after the initial dose. They may select a second dose of the Johnson & Johnson COVID-19 vaccine or a booster dose of either the Pfizer-BioNTech or Moderna COVID-19 vaccines.

    The American Heart Association/American Stroke Association, a global force for longer, healthier lives for all, affirms the CDC’s guidance on COVID-19 vaccines.

    The Association remains concerned about the continuing gaps in COVID-19 vaccination among people from all eligible age groups in the U.S. including people from diverse racial and ethnic groups and among pregnant women, especially in light of the Omicron variant. Therefore, it continues to urge all adults and children ages 5 and older in the U.S. to receive all COVID-19 vaccines as soon as they are eligible, as recommended by the CDC and fully approved or authorized for emergency use by the FDA.

    "With the Omicron variant spreading, we urge everyone 5 and older to get vaccinated against COVID-19 and get the booster when they are eligible. The booster shots are particularly important for adults ages 50 and older who have underlying medical conditions or any adult living in a long-term care facility," said American Heart Association volunteer President Donald M. Lloyd-Jones, M.D., Sc.M., FAHA, who is also the Eileen M. Foell Professor of Heart Research, professor of preventive medicine, medicine and pediatrics, and chair of the department of preventive medicine at Northwestern University’s Feinberg School of Medicine in Chicago.

    "As cited by the CDC, recently published research indicates a COVID-19 vaccine booster dose provides increased protection against COVID-19 infection, severe complications and death. Breakthrough cases of COVID-19 infection after vaccination are possible, however, serious side effects and needing hospitalization among people who are vaccinated continue to be rare and mild. The benefits of the vaccine and boosters far outweigh the very limited risk."

    The Association also supports the CDC’s ongoing safety recommendations: mask wearing for all people regardless of vaccination status when indoors, frequent handwashing and social distancing. Along with COVID-19 vaccination, these safety protocols are essential to minimizing the spread of the COVID-19 virus and reducing the risk of infection, hospitalization and death.

    "As the COVID-19 pandemic impacts our families and communities for a second winter and holiday season, we encourage everyone to remain vigilant against the COVID-19 virus. The COVID-19 vaccines are paramount to saving lives, protecting our families and loved ones against COVID-19 infection, severe illness and death. We urge everyone to get vaccinated as soon as possible so that it is a winter filled with joyous memories," urged Lloyd-Jones.

    Updated COVID-19 vaccine approved by FDA coming soon

    by Matt Sheehan
    OSF Healthcare

    Photo provided
    Dr. Doug Kasper
    PEORIA - The fall virus season is upon us, and the U.S. Food & Drug Administration just approved one of the newest tools to protect Americans from severe illness.

    The updated COVID-19 vaccine is expected to be available at pharmacies around the country in the coming weeks.

    The mRNA vaccine is not a booster, says Doug Kasper, MD, an infectious disease specialist with OSF HealthCare. He says it’s recommended for a much broader portion of the population.

    "The vaccine is now recommended for everybody 6 months and older as a one-time, once-a-year vaccine," Dr. Kasper says. “The vaccine has been updated. For people who are at really high risk, those 65 and older or with respiratory conditions, they may get a second shot. This would be in a six-month interval in the springtime.”

    Does the vaccine prevent me from getting COVID-19?
    The quick answer? No, much like you find with the annual influenza vaccine.

    "The vaccine seeks to protect severe outcomes associated with COVID-19. It doesn't protect you from getting COVID, it tries to decrease the severity of how sick you would get," Dr. Kasper says.

    While there has been an uptick in COVID-19 cases recently, Dr. Kasper says there has not been an increase in COVID hospitalizations. He attributes this to robust natural immunity in the population and adding this COVID-19 vaccine is just another way to protect yourself from severe illness.

    FDA’s “What to Know” sheet
    The 2024-2025 formula has been updated to protect against the Omicron variant KP.2.

    • Unvaccinated individuals 6 months through 4 years of age are eligible to receive three doses of the updated, authorized Pfizer-BioNTech COVID-19 vaccine or two doses of the updated, authorized Moderna COVID-19 vaccine.
    • Individuals 6 months through 4 years of age who have previously been vaccinated against COVID-19 are eligible to receive one or two doses of the updated, authorized Moderna or Pfizer-BioNTech COVID-19 vaccines (timing and number of doses to administer depends on the previous COVID-19 vaccine received).
    • Individuals 5 years through 11 years of age regardless of previous vaccination are eligible to receive a single dose of the updated, authorized Moderna or Pfizer-BioNTech COVID-19 vaccines; if previously vaccinated, the dose is administered at least two months after the last dose of any COVID-19 vaccine.
    • Individuals 12 years of age and older are eligible to receive a single dose of the updated, approved Comirnaty (manufactured by Pfizer BioNTech) or the updated, approved Spikevax (manufactured by Moderna); if previously vaccinated, the dose is administered at least two months since the last dose of any COVID-19 vaccine.
    • Additional doses are authorized for certain immunocompromised individuals ages 6 months through 11 years of age as described in the Moderna COVID-19 vaccine and Pfizer-BioNTech COVID-19 vaccine fact sheets.
    Commercial retailers are the way to go
    As the vaccines from Pfizer and Moderna become available, the Centers for Disease Control & Prevention (CDC) will publish a pharmacy lookup website at https://www.vaccines.gov/en/vaccines.gov to help people find the nearest vaccine locations.

    Dr. Kasper says the best bet at getting a vaccine appointment for COVID-19 or influenza, is through pharmacies at local commercial retailers like Target, Walgreens, CVS or Walmart.

    Free COVID-19 home tests are coming back
    “The U.S. government will make the at-home COVID testing available for free again this year. You can request up to four home tests that will be delivered to your address for free,” Dr. Kasper says. That gives people another option for testing if they think they're developing signs of COVID even after receiving a vaccine, which can be another way to avoid wait lines at urgent cares, ERs or primary care clinics, and to keep themselves isolated until symptoms have resolved.”

    The U.S. Department of Health & Human Services reports that COVIDTests.gov will be the website to order from once the website is active.

    Status of the Novavax vaccine
    A third manufacturer, Novavax, makes a protein-based vaccine similar to influenza vaccines. While it hasn’t been approved by the FDA, Dr. Kasper suspects it will be soon.

    "It likely will be approved, and Novavax has been a prior manufacturer of COVID-19 vaccines. That is a third option that will be coming that isn't mRNA based for people to consider if they had an adverse reaction with Pfizer or Moderna in the past,” Dr. Kasper says.

    Can I get the COVID-19 and flu vaccine at the same time?
    "There's no issue with timing on getting the COVID and influenza vaccines. The RSV vaccine is recommended to be given separate," Dr. Kasper says. “Most of that has to do with the fact they weren't studied together, there's not an adverse issue with it. For the population, COVID and influenza are recommended across almost all age groups. RSV is for our older population, so we recommend spacing that out by a week or two.”

    For all vaccine questions, Dr. Kasper recommends speaking with your primary care team to review your options.


    Read our latest health and medical news

    Don't have health insurance for an updated COVID-19 vaccine? Here's how to get one free

    BrandPoint - While COVID-19 activity is still below the levels seen last year at this time, COVID-19 hospitalizations are rising quickly. There is still time to get yourself and your loved ones vaccinated. Getting an updated COVID-19 vaccine is the best way to stay protected against serious illness from COVID-19. The Centers for Disease Control and Prevention (CDC) recommends that everyone 6 months and older stay up to date with COVID-19 vaccination. Vaccination also lowers your risk of getting long COVID - a wide range of health problems that can last weeks, months or even years after COVID-19 infection.

    Most adults can get a free updated COVID-19 vaccine through their private health insurance, Medicare or Medicaid plans. However, some health insurance plans don't fully cover the cost of a COVID-19 vaccine, and an estimated 25-30 million people living in the U.S. don't have health insurance.

    To address this concern, CDC's Bridge Access Program is offering adults who are uninsured or whose insurance doesn't fully cover COVID-19 vaccination a free, updated COVID-19 vaccine. This program will end by Dec. 31, 2024. To date, more than a million COVID-19 vaccine doses have been provided through the program.

    Bridge Access Program

    There is no enrollment process or application to qualify, and you don't need to provide identification or proof of insurance to get a vaccine through the Bridge Access Program. If you are 18 years or older and don't have health insurance, or your plan doesn't fully cover an updated COVID-19 vaccine, the Bridge Access Program can provide one for free at participating CVS, Walgreens and eTrueNorth-partnering pharmacies, local health centers and health providers.

    How to find a vaccine through the Bridge Access Program

    Follow these steps to find pharmacies and health care providers participating in the Bridge Access Program near you:

    * Visit Vaccines.gov.

    * Select "Find COVID-19 Vaccines."

    * Enter your 5-digit ZIP code in the search bar and select which vaccine option(s) you're interested in finding.

    * Select "Search for COVID-19 Vaccines."

    * Select the option "Bridge Access Program Participant" to show participating providers and pharmacies.

    When you find a convenient location, call ahead to confirm that they can provide you with a free updated COVID-19 vaccine through the Bridge Access Program. If you can't find a participating pharmacy or provider near you, check back later because new locations are still being added.

    Why get vaccinated now?

    Viruses constantly change through mutation and sometimes these mutations result in a new strain (or variant) of the virus. It's important to know that the updated COVID-19 vaccines offer protection against the variants spreading throughout our communities right now.

    The cold winter months are a time when people spend more time in crowded indoor settings, where respiratory viruses, including COVID-19, may be more readily transmitted. Getting an updated COVID-19 vaccine will help protect you from serious illness.

    Don't let cost stop you from getting an updated COVID-19 vaccine this year. Free COVID-19 vaccines are still available. If you are uninsured or your plan won't fully cover it, visit Vaccines.gov today to find a Bridge Access Program provider near you.


    Government oversight was in short supply as patients become infected with Covid at hospitals

    by Lauren Weber and Christina Jewett, Kaiser Health News

    One by one, the nurses taking care of actress Judi Evans at Riverside Community Hospital kept calling out sick.

    Patients were coughing as staffers wheeled the maskless soap opera star around the California hospital while treating her for injuries from a horseback fall in May 2020, Evans said.



    Hospitals, like Riverside, with high rates of covid patients who didn’t have the diagnosis when they were admitted have rarely been held accountable due to multiple gaps in government oversight, a KHN investigation has found.


    She remembered they took her to a room to remove blood from her compressed lung where another maskless patient was also getting his lung drained. He was crying out that he didn’t want to die of covid.

    No one had told her to wear a mask, she said. “It didn’t cross my mind, as I’m in a hospital where you’re supposed to be safe.”

    Then, about a week into her hospital stay, she tested positive for covid-19. It left the 57-year-old hospitalized for a month, staring down more than $1 million in bills for treatment costs and suffering from debilitating long-haul symptoms, she said.

    Hospitals, like Riverside, with high rates of covid patients who didn’t have the diagnosis when they were admitted have rarely been held accountable due to multiple gaps in government oversight, a KHN investigation has found.

    While a federal reporting system closely tracks hospital-acquired infections for MRSA and other bugs, it doesn’t publicly report covid caught in individual hospitals.

    Health News on The Sentinel

    Medicare officials, tapped by Congress decades ago to ensure quality care in hospitals, also discovered a gaping hole in their authority as covid spread through the nation. They could not force private accreditors — which almost 90% of hospitals pay for oversight — to do targeted infection-control inspections. That means Riverside and nearly 4,200 other hospitals did not receive those specific covid-focused inspections, according to a government watchdog report, even though Medicare asked accreditors to do them in March 2020.

    Seema Verma, former chief of Medicare and Medicaid under President Donald Trump, said government inspectors went into nearly every nursing home last year. That the same couldn’t be done for hospitals reveals a problem. “We didn’t have the authority,” she told KHN. “This is something to be corrected.”

    KHN previously reported that at least 10,000 patients nationwide were diagnosed with covid in hospitals last year after being admitted for something else — a sure undercount of the infection’s spread inside hospitals, since that data analysis primarily includes Medicare patients 65 and older.

    Nationally, 1.7% of Medicare inpatients were documented as having covid diagnosed after being admitted for another condition, according to data from April through September 2020 that hospitals reported to Medicare. CDIMD, a Nashville-based consulting and data analytics company, analyzed the data for KHN.

    At Riverside Community Hospital, 4% of the covid Medicare patients were diagnosed after admission — more than double the national average. At 38 other hospitals, that rate was 5% or higher. All those hospitals are approved by private accreditors, and 29 of them hold “The Gold Seal of Approval” from their accreditor.

    To be sure, the data has limitations: It represents a difficult time in the pandemic, when protective gear and tests were scarce and vaccines were not yet available. And it could include community-acquired cases that were slow to show up. But hospital-employed medical coders decide whether a case of covid was present on admission based on doctors’ notes, and are trained to query doctors if it’s unclear. Some institutions fared better than others — while the American public was left in the dark.

    Spurred by serious complaints, federal inspectors found infection-control issues in few of those 38 hospitals last year. In Michigan, inspectors reported that one hospital “failed to provide and maintain a sanitary environment resulting in the potential for the spread of infectious disease to 151 served by the facility.” In Rhode Island, inspectors found a hospital “​​failed to have an effective hospital-wide program for the surveillance and prevention” of covid.

    KHN was able to find federal inspection reports documenting infection-control issues for eight of those 38 hospitals. The other 30 hospitals around the country, from Alabama to Arizona, had no publicly available federal records of infection-control problems in 2020.

    KHN found that even when state inspectors in California assessed hospitals with high rates of covid diagnosed after admission, they identified few shortcomings.

    “The American public thinks someone is watching over them,” said Lisa McGiffert, co-founder of the Patient Safety Action Network, an advocacy group. “Generally they think someone’s in charge and going to make sure bad things don’t happen. Our oversight system in our country is so broken and so untrustworthy.”

    The data shows that the problem has deadly consequences: About a fifth of the Medicare covid patients who were diagnosed after admission died. And it was costly as well. In California alone, the total hospital charges for such patients from April through December last year was over $845 million, according to an analysis done for KHN by the California Department of Health Care Access and Information.

    The Centers for Disease Control and Prevention has pledged funding for increased infection-control efforts — but that money is not focused on tracking covid’s spread in hospitals. Instead, it will spend $2.1 billion partly to support an existing tracking system for hospital-acquired pathogens such as MRSA and C. diff.

    The CDC does not currently track hospital-acquired covid, nor does it plan to do so with the additional funding. That tracking is done by another part of the U.S. Department of Health and Human Services, according to Dr. Arjun Srinivasan, associate director for the CDC’s health care-associated infection-prevention programs. But it’s not made public on a hospital-by-hospital basis. HHS officials did not respond to questions.

    The Scene at Riverside

    In March 2020, Evans was alarmed by nonstop TV footage of covid deaths, so she and her husband locked down. They hadn’t been going out much, anyway, since losing their only child at the end of 2019 to another public health crisis — fentanyl.

    At the time, concerns about covid were mounting among the staff at Riverside Community Hospital, a for-profit HCA Healthcare facility.

    The hospital’s highly protective N95 masks had been pulled off the supply room shelves and put in a central office, according to Monique Hernandez, a shop steward for her union, Service Employees International Union Local 121RN. Only nurses who had patients getting aerosol-generating procedures such as intubation — which were believed at the time to spread the virus — could get one, she said.

    She said that practice left the nurses on her unit with a difficult choice: either say you had a patient undergoing such procedures or risk getting sick.

    Nurse unions were early adopters of the notion — now widely accepted — that covid is spread by minuscule particles that can linger in the air. Studies since have matched the genetic fingerprint of the virus to show that covid has spread among workers or patients wearing surgical masks instead of more protective masks like N95s.

    On April 22, 2020, Hernandez and other nurses joined a silent protest outside the hospital where they held up signs saying “PPE Over Profit.” By that time, the hospital had several staff clusters of infection, according to Hernandez, and she was tired of caregivers being at risk.

    In a statement, Riverside spokesperson David Maxfield said the hospital’s top priority has been to protect staff “so they can best care for our patients.”

    “Any suggestion otherwise ignores the extensive work, planning and training we have done to ensure the delivery of high-quality care during this pandemic,” he said.

    In mid-May, Judi Evans’ husband coaxed her into going horseback riding — one of the few things that brought her joy after her son’s death. On her second day back in the saddle, she was thrown from her horse. She broke her collarbone and seven ribs, and her lung was compressed. She was taken to Riverside Community Hospital.

    There, many of her nurses wore masks they had previously used, Evans recalled. Other staffers came in without any masks at all, she said. A few days in, she said, one of the doctors told her it’s crazy that the hospital was testing her for MRSA and other hospital infections but not covid.

    Maxfield said that the hospital began enforcing a universal mask mandate for staff and visitors on March 31, 2020, and, “in line with CDC, patients were and are advised to wear masks when outside their room if tolerated.” He stressed “safety of our patients and colleagues has been our top priority.”

    After about a week in the hospital, Evans said, she spiked a fever and begged for a covid test. It was positive. There is no way to know for certain where or how she got infected but she believes it was at Riverside. Covid infections can take two to 14 days from exposure to show symptoms like a fever, with the average being four to five days. According to CDC guidance, infection onset that occurs two days or more after admission could be “hospital-associated.”

    Doctors told her they might have to amputate her legs when they began to swell uncontrollably, she said.

    “It was like being in a horror film — one of those where everything that could go wrong does go wrong,” Evans said.

    She left with over $1 million in bills from a month-long stay — and her legs, thankfully. She said she still suffers from long-covid symptoms and is haunted by the screams of fellow patients in the covid ward.

    By the end of that year, Riverside Community Hospital would report that 58 of its 1,649 covid patients were diagnosed with the virus after admission, according to state data that covers all payers from April to December.

    That’s nearly three times as high as the California average for covid cases not present on admission, according to the analysis for KHN by California health data officials.

    “Based on contact tracing, outlined by the CDC and other infectious disease experts, there is no evidence to suggest the risk of transmission at our hospital is different than what you would find at other hospitals,” Maxfield said.

    A lawsuit filed in August by the SEIU-United Healthcare Workers West on behalf of the daughter of a hospital lab assistant who died of covid and other hospital staffers says the hospital forced employees to work without adequate protective gear and while sick and “highly contagious.”

    The hospital “created an unnecessarily dangerous work environment,” the lawsuit claims, “which in turn has created dangerous conditions for patients” and a “public nuisance.”

    Attorneys for Riverside Community Hospital are fighting the ongoing lawsuit. “This lawsuit is an attempt for the union to gain publicity, and we have filed a motion to end it,” said Maxfield, the hospital spokesperson.

    The hospital’s lawyers have said the plaintiffs got covid during a spike in local cases and are only speculating that they contracted the virus at the hospital, according to records filed in Riverside County Superior Court.

    They also said in legal filings that the court should not step into the place of “government agencies who oversee healthcare and workplace safety” and “handled the response to the pandemic.”

    ‘A Shortcoming in the Oversight System’

    Decades ago, Congress tasked Medicare with ensuring safe, quality care in U.S. hospitals by building in routine government inspections. However, hospitals can opt to pay up to tens of thousands of dollars per year to nongovernmental accreditors entrusted by CMS to certify the hospitals as safe. So 90% do just that.

    But these accrediting agencies — including the Joint Commission, which certified Riverside — are private organizations. Thus they are not required to follow CMS’ directives, including the request in a March 20 memo urging the accrediting agencies to execute targeted infection-control surveys aimed at preparing hospitals for covid’s onslaught.

    And so they didn’t send staffers to survey hospitals for the specialized infection-control inspections in 2020, according to a June 2021 Health and Human Services Office of the Inspector General report.

    Riverside, despite allegations of lax practices, holds The Gold Seal of Approval from the Joint Commission, which last inspected the hospital on-site in May 2018 before going in on Nov. 19 this year.

    The inspector general’s office urged CMS to pursue the authority to require special surveys in a health emergency — lest it lose control of its mission to keep hospitals safe.

    “CMS could not ensure that accredited hospitals would continue to provide quality care and operate safely during the COVID-19 emergency,” and could not ensure it going forward, the report said.

    “We’re telling CMS to do their job,” the report’s author, Assistant Regional Inspector General Calvin Jones, said in an interview. “The covid experience really showed a shortcoming in the oversight system.”

    CMS spokesperson Raymond Thorn said the agency agrees with the report’s recommendation and will work on a regulation after the public health emergency ends.

    Accrediting agencies, however, pushed back on the inspector general’s findings. Among them: DNV Healthcare USA Inc. Its director of accreditation, Troy McCann, said there was not a gap in oversight. Although he said travel restrictions limited accreditors ability to fly across state lines, his group continued its annual reviews after May 2020 and incorporated the special focus on infection control into them. “We have a strong emphasis, always, on safety, infection control and emergency preparedness, which has left our hospitals stronger,” McCann said.

    Angela FitzSimmons, spokesperson for the Accreditation Commission for Health Care, said that the accrediting organization’s surveys typically focus on infection control, and the group worked during the pandemic to prioritize hospitals with prior issues in the area of infection prevention.

    “We did not deem it necessary to add random surveys that would occur at a cost to the hospital without just cause,” FitzSimmons said.

    Maureen Lyons, a spokesperson for the Joint Commission, told KHN that, after evaluating CMS guidance, the nonprofit group decided it would incorporate the infection-control surveys into its surveys done every three years and, in the meantime, provide hospitals with the latest federal guidance on covid.

    “Hospitals were operating in extremis. Thus, we collaborated closely with CMS to determine optimal strategies during this time of emergency,” she said.

    The Joint Commission cited safety issues for its inspectors, who travel to the hospitals and need proper protective equipment that was running low at the time, as part of the reason for its decision.

    Verma, the CMS administrator at the time, pushed back on accreditors’ travel safety concerns, saying that “narrative doesn’t quite fit because the state and CMS surveyors were going into nursing homes.”

    Though Verma cautioned that hospitals were overwhelmed by the crush of covid patients, “doing these inspections may have helped hospitals bolster their infection-control practices,” she said. “Without these surveys, we really have no way of knowing.”

    ‘Immediate Jeopardy’

    Medicare inspectors can go into a privately accredited hospital after they get a serious complaint. They found alarming circumstances when they visited some of the hospitals with high rates of covid diagnosed after a patient was admitted for another concern last year.

    At Levindale Hebrew Geriatric Center and Hospital in Baltimore, the July 2020 inspection report says “systemic failures left the hospital and all of its patients, staff, and visitors vulnerable to harm and possible death from COVID-19.”

    In response, hospital spokesperson Sharon Boston said that “we have seen a large decrease in the spread of the virus at Levindale.”

    Inspectors had declared a state of “immediate jeopardy” after they investigated a complaint and discovered an outbreak that began in April and continued through the beginning of July, with more than 120 patients and employees infected with covid. And in a unit for those with Alzheimer’s and other conditions, 20% of the 55 patients who had covid died.

    The hospital moved patients whose roommates tested positive for covid to other shared rooms, “potentially exposing their new roommate,” the inspection report said. Boston said that was an “isolated” incident and the situation was corrected the next day, with new policies put in place.

    The Medicare data analyzed exclusively for KHN shows that 52 of Levindale’s 64 covid hospital patients, or 81%, were diagnosed with covid after admission from April to September 2020. Boston cited different numbers over a different time period: Of 67 covid patients, 64 had what she called “hospital-acquired” covid from March to June 2020. That would be nearly 96%.

    The hospital shares space with a nursing home, though, so KHN did not group it with the general short-term acute-care hospitals as part of the analysis. Levindale’s last Joint Commission on-site survey was in December 2018, resulting in The Gold Seal of Approval. It had not had its once-every-three-years survey as of Dec. 10, 2021, according to the Joint Commission’s tracking.

    Boston said Levindale “quickly addressed” the issues that Medicare inspectors cited, increasing patient testing and more recently mandating staff vaccines. Since December 2020, Boston said, the facility has not had a covid patient die.

    At the state level, hospital inspectors in California found few problems to cite even at hospitals where 5% or more patients were diagnosed with covid after they were admitted for another concern. Fifty-three complaints about such hospitals went to the Department of Public Health from April until the end of 2020. Only three of those complaints resulted in a finding of deficiency that facility was expected to fix.

    CDPH did not respond to requests for comment.

    A New Chapter

    Things are better now at Riverside Community Hospital, Hernandez said. She is pleased with the current safety practices, including more protective gear and HEPA filters for covid patients’ rooms. For Hernandez, though, it all comes too late now.

    “We laugh at it,” she said, “but it hurts your soul.”

    Evans said she was able to negotiate her $1 million-plus hospital bills down to roughly $70,000.

    Her covid aftereffects have been ongoing — she said she stopped gasping for air and reaching for her at-home oxygen tank only a few months ago. She still hasn’t been able to return to work full time, she said.

    For the past year, her husband would wake up in the middle of the night to check whether her oxygen levels were dipping. Terrified of losing her, he’d slip an oxygen mask on her face, she said.

    “I would walk 1,000 miles to go to another hospital,” Evans said, if she could do it all over again. “I would never step foot in that hospital again.”

    Methodology

    KHN requested custom analyses of Medicare, California and Florida inpatient hospital data to examine the number of covid-19 cases diagnosed after a patient’s admission.

    The Medicare and Medicare Advantage data, which includes patients who are 65 and older, is from the Centers for Medicare & Medicaid Services’ Medicare Provider Analysis and Review (MedPAR) file and was analyzed by CDIMD, a Nashville-based medical code consulting and data analytics firm. The data is from April 1 through Sept. 30, 2020. The data for the fourth quarter of 2020 was not yet available.

    The data shows the number of inpatient Medicare hospital stays in the U.S., including the number of people diagnosed with covid-19 and the number of admissions for which the covid diagnosis was not “present on admission.” CMS considers some medical conditions that are not “present on admission” to be hospital-acquired, according to the agency. The data is for general acute-care hospitals, which may include a psychiatric floor, and not for other hospitals such as those in the Department of Veterans Affairs system or stand-alone psychiatric hospitals.

    KHN requested a similar analysis from California’s Department of Health Care Access and Information of its hospital inpatient data. That data was from April 1 through Dec. 31, 2020, and covered patients of all ages and payer types and, in general, private psychiatric and long-term acute-care hospitals. Etienne Pracht, a University of South Florida researcher, provided the number of Florida covid patients who did not have the virus upon hospital admission for all ages and payer types at general and psychiatric hospitals from April 1 through Dec. 31, 2020. KHN subtracted the number of Medicare patients in the MedPAR data from the Florida and California datasets so they would not be counted twice.

    To calculate the rate of hospitalized Medicare patients who tested positive for covid — and died — KHN relied on the MedPAR data for April through September. That data includes records for 6,629 seniors, 1,409 of whom, or 21%, died. California data for all ages and payer types from April through December shows a similar rate: Of 2,115 diagnosed with covid-19 after hospital admission, 435, or 21%, died. The MedPAR data was also used to calculate the national rate of 1.7%, with 6,629 of 394,939 covid patients diagnosed with the virus whose infections were deemed not present on admission, according to the CDIMD analysis of data that hospitals report to Medicare. It was also used to calculate which entities licensed as short-term acute care hospitals had 5% or more of their covid cases diagnosed within the hospital. As stated in the story, Levindale Hebrew Geriatric Center and Hospital in Baltimore was not included in that list of 38 because it shares space with a nursing home and had fewer than 500 total discharges.

    Data that hospitals submit to Medicare on whether an inpatient hospital diagnosis was “present on admission” is used by Medicare for payment determinations and is intended to incentivize hospitals to prevent infections during hospital care. The federal Agency for Healthcare Research and Quality also uses the data to “assist in identifying quality of care issues.”

    Whether covid-19 is acquired in a hospital or in the community is measured in different ways. Some nations assume the virus is hospital-acquired if it is diagnosed seven or more days after admission, while U.S. data counts cases only after 14 days.

    Hospitals’ medical coders who examined patient records for the data analyzed for this KHN report focus on each physician’s admission, progress and discharge notes to determine whether covid was “present on admission.” They do not have a set number of days they look for and are trained to query physicians if the case is unclear, according to Sue Bowman, senior director of coding policy and compliance at the American Health Information Management Association.

    KHN tallied the cases in which covid-19 was logged in the data as not “present on admission” to the hospital. Some covid cases are coded as “U” for having insufficient documentation to make a determination. Since Medicare and AHRQ consider the “U” to be an “N” (or not present on admission) for the purposes of payment decisions and quality indicators, KHN chose to count those cases in the grand total.

    In 409 of 6,629 Medicare cases and in 70 of 2,185 California cases, the “present on admission” indicator was “U.” The Florida data did not include patients whose “present on admission” indicator was “U.” Medical coders have another code, “W,” for “clinically undetermined” cases, which consider a condition present on admission for billing or quality measures. Medical coders use the “U” (leaning toward “not present on admission”) and “W” (leaning toward “present on admission”) when there is some uncertainty about the case. KHN did not count “W” cases.

    The Medicare MedPAR data includes about 2,500 U.S. hospitals that had at least a dozen covid-19 cases from April through September 2020. Of those, 1,070 reported no cases of covid diagnosed after admission for other conditions in the Medicare records. Data was suppressed due to privacy reasons for about 1,300 hospitals that had between one and 11 of such covid cases. There were 126 hospitals reporting 12 or more cases of covid that were “not present on admission” or unknown. For those, we divided the number of cases diagnosed after admission by the total number of patients with covid to arrive at the rate, as is standard in health care.

    Inspection and Accreditation Analysis

    To evaluate which of the 38 hospitals detailed above had federal inspection reports documenting infection-control issues, KHN searched CMS’ publicly available “2567” reports, which detail deficiencies for each hospital for 2020. For surveys listed online as “not available,” KHN requested and obtained them from CMS. KHN further asked CMS to double-check the remaining hospitals for any inspection reports that weren’t posted online. KHN also checked the Association of Health Care Journalists’ database http://www.hospitalinspections.org/ for each of the 38 hospitals for any additional reports, as well as CMS’ Quality, Certification and Oversight Reports site.

    To check that each of these hospitals was accredited, KHN looked up each hospital using a site run by the Joint Commission and reached out to the accreditors DNV Healthcare USA Inc. and the Accreditation Commission for Health Care.

    To tabulate infection-control complaints for hospitals at the state level in California, KHN used data available through the California Department of Public Health’s Cal Health Find Database. KHN searched the database for the hospitals that had higher than 5% of covid patients being diagnosed after admission, according to the California data, and tallied all complaints and deficiencies found involving infection control from April to December 2020.

    KHN (Kaiser Health News) is a national newsroom that produces in-depth journalism about health issues. Together with Policy Analysis and Polling, KHN is one of the three major operating programs at KFF (Kaiser Family Foundation). KFF is an endowed nonprofit organization providing information on health issues to the nation.

    The new Covid vaccine has been approved, why you might not want to rush out to get it yet

    by Arthur Allen and Eliza Fawcett, Healthbeat
    Rebecca Grapevine, Healthbeat

    Because viruses evolve as they infect people, the CDC has recommended updated covid vaccines each year.

    The FDA has approved an updated covid shot for everyone 6 months old and up, which renews a now-annual quandary for Americans: Get the shot now, with the latest covid outbreak sweeping the country, or hold it in reserve for the winter wave?

    The new vaccine should provide some protection to everyone. But many healthy people who have already been vaccinated or have immunity because they’ve been exposed to covid enough times may want to wait a few months.

    Covid has become commonplace. For some, it’s a minor illness with few symptoms. Others are laid up with fever, cough, and fatigue for days or weeks. A much smaller group — mostly older or chronically ill people — suffer hospitalization or death.

    It’s important for those in high-risk groups to get vaccinated, but vaccine protection wanes after a few months. Those who run to get the new vaccine may be more likely to fall ill this winter when the next wave hits, said William Schaffner, an infectious disease professor at Vanderbilt University School of Medicine and a spokesperson for the National Foundation for Infectious Diseases.

    On the other hand, by late fall the major variants may have changed, rendering the vaccine less effective, said Peter Marks, the FDA’s top vaccine official, at a briefing Aug. 23. He urged everyone eligible to get immunized, noting that the risk of long covid is greater in the un- and undervaccinated.

    Of course, if last year’s covid vaccine rollout is any guide, few Americans will heed his advice, even though this summer’s surge has been unusually intense, with levels of the covid virus in wastewater suggesting infections are as widespread as they were in the winter.

    The Centers for Disease Control and Prevention now looks to wastewater as fewer people are reporting test results to health authorities. The wastewater data shows the epidemic is worst in Western and Southern states. In New York, for example, levels are considered “high” — compared with “very high” in Georgia.

    Hospitalizations and deaths due to covid have trended up, too. But unlike infections, these rates are nowhere near those seen in winter surges, or in summers past. More than 2,000 people died of covid in July — a high number but a small fraction of the at least 25,700 covid deaths in July 2020.

    Partial immunity built up through vaccines and prior infections deserves credit for this relief. A new study suggests that current variants may be less virulent — in the study, one of the recent variants did not kill mice exposed to it, unlike most earlier covid variants.

    Covid rapid tests will no longer be free

    Alexandra Koch/Pixabay

    Public health officials note that even with more cases this summer, people seem to be managing their sickness at home. “We did see a little rise in the number of cases, but it didn’t have a significant impact in terms of hospitalizations and emergency room visits,” said Manisha Juthani, public health commissioner of Connecticut, at a news briefing Aug. 21.

    Unlike influenza or traditional cold viruses, covid seems to thrive outside the cold months, when germy schoolkids, dry air, and indoor activities are thought to enable the spread of air- and saliva-borne viruses. No one is exactly sure why.

    “Covid is still very transmissible, very new, and people congregate inside in air-conditioned rooms during the summer,” said John Moore, a virologist and professor at Cornell University’s Weill Cornell Medicine College.

    Or “maybe covid is more tolerant of humidity or other environmental conditions in the summer,” said Caitlin Rivers, an epidemiologist at Johns Hopkins University.

    Because viruses evolve as they infect people, the CDC has recommended updated covid vaccines each year. Last fall’s booster was designed to target the omicron variant circulating in 2023. This year, mRNA vaccines made by Moderna and Pfizer and the protein-based vaccine from Novavax — which has yet to be approved by the FDA — target a more recent omicron variant, JN.1.

    The FDA determined that the mRNA vaccines strongly protected people from severe disease and death — and would do so even though earlier variants of JN.1 are now being overtaken by others.

    Public interest in covid vaccines has waned, with only 1 in 5 adults getting vaccinated since last September, compared with about 80% who got the first dose. New Yorkers have been slightly above the national vaccination rate, while in Georgia only about 17% got the latest shot.

    Vaccine uptake is lower in states where the majority voted for Donald Trump in 2020 and among those who have less money and education, less health care access, or less time off from work. These groups are also more likely to be hospitalized or die of the disease, according to a 2023 study in The Lancet.

    While the newly formulated vaccines are better targeted at the circulating covid variants, uninsured and underinsured Americans may have to rush if they hope to get one for free. A CDC program that provided boosters to 1.5 million people over the last year ran out of money and is ending Aug. 31.

    The agency drummed up $62 million in unspent funds to pay state and local health departments to provide the new shots to those not covered by insurance. But “that may not go very far” if the vaccine costs the agency around $86 a dose, as it did last year, said Kelly Moore, CEO of Immunize.org, which advocates for vaccination.

    People who pay out-of-pocket at pharmacies face higher prices: CVS plans to sell the updated vaccine for $201.99, said Amy Thibault, a spokesperson for the company.

    “Price can be a barrier, access can be a barrier” to vaccination, said David Scales, an assistant professor of medicine at Weill Cornell Medical College.

    Without an access program that provides vaccines to uninsured adults, “we’ll see disparities in health outcomes and disproportionate outbreaks in the working poor, who can ill afford to take off work,” Kelly Moore said.

    New York state has about $1 million to fill the gaps when the CDC’s program ends, said Danielle De Souza, a spokesperson for the New York State Department of Health. That will buy around 12,500 doses for uninsured and underinsured adults, she said. There are roughly one million uninsured people in the state.

    CDC and FDA experts last year decided to promote annual fall vaccination against covid and influenza along with a one-time respiratory syncytial virus shot for some groups.

    It would be impractical for the vaccine-makers to change the covid vaccine’s recipe twice every year, and offering the three vaccines during one or two health care visits appears to be the best way to increase uptake of all of them, said Schaffner, who consults for the CDC’s policy-setting Advisory Committee on Immunization Practices.

    At its next meeting, in October, the committee is likely to urge vulnerable people to get a second dose of the same covid vaccine in the spring, for protection against the next summer wave, he said.

    If you’re in a vulnerable population and waiting to get vaccinated until closer to the holiday season, Schaffner said, it makes sense to wear a mask and avoid big crowds, and to get a test if you think you have covid. If positive, people in these groups should seek medical attention since the antiviral pill Paxlovid might ameliorate their symptoms and keep them out of the hospital.

    As for conscientious others who feel they may be sick and don’t want to spread the covid virus, the best advice is to get a single test and, if positive, try to isolate for a few days and then wear a mask for several days while avoiding crowded rooms. Repeat testing after a positive result is pointless, since viral particles in the nose may remain for days without signifying a risk of infecting others, Schaffner said.

    The Health and Human Services Department is making four free covid tests available to anyone who requests them starting in late September through covidtest.gov, said Dawn O’Connell, assistant secretary for preparedness and response, at the Aug. 23 briefing.

    The government is focusing its fall vaccine advocacy campaign, which it’s calling “Risk less, live more,” on older people and nursing home residents, said HHS spokesperson Jeff Nesbit.

    Not everyone may really need a fall covid booster, but “it’s not wrong to give people options,” John Moore said. “The 20-year-old athlete is less at risk than the 70-year-old overweight dude. It’s as simple as that.”

    KFF Health News correspondent Amy Maxmen contributed to this report.

    Healthbeat is a nonprofit newsroom covering public health published by Civic News Company and KFF Health News. Sign up for their newsletters here.

    KFF Health News is a national newsroom that produces in-depth journalism about health issues and is one of the core operating programs at KFF—an independent source of health policy research, polling, and journalism. Learn more about KFF.

    Subscribe to KFF Health News' free Morning Briefing.

    Covid-19 declaration ends on May 11, testing and treatment coverage costs will be passed on to patients

    Alexandra Koch/Pixabay

    Before the PHE ends, people are encouraged to order free COVID-19 tests from the government and get up to date on vaccinations. COVID-19 healthcare costs, insurance coverage, and benefits set to change dramatically.
    by Champaign-Urbana Public Health District

    Champaign – On May 11, 2023, the COVID-19 public health emergency (PHE) will officially end, marking a significant milestone in the fight against the pandemic. The declaration of the PHE was initially made on January 31, 2020 to mobilize and coordinate a nationwide response to the COVID-19 outbreak. The state of Illinois followed on March 9, 2020. Since then, Illinois residents could collect additional SNAP benefits, more than 1.4 million children received pandemic EBT (nutrition) support, and Medicaid benefits expanded so residents could access telehealth and additional resources.

    Before the PHE ends, people are encouraged to order free COVID-19 tests from the government (four tests per residential address) and get up to date on vaccinations. Individuals can check if they are up to date by visiting https://www.cdc.gov/coronavirus/2019-ncov/vaccines/stay-up-to-date.html and can find where to receive vaccines by visiting vaccines.gov for pharmacy locations or by visiting https://www.c-uphd.org/covid-vaccinations.html. Individuals with healthcare facilities should call their provider’s office for more information or to set up an appointment. Free at-home COVID tests can be ordered at https://special.usps.com/testkits or by calling 1-800-232-0233.

    Beginning May 11, coverage for COVID-19 testing will change. The requirement for private insurance companies to cover COVID-19 tests without cost sharing, both over-the-counter (OTC) and laboratory tests, will end and individuals should reach out to their insurance provider for details. The Centers for Disease Control and Prevention (CDC) Increasing Community Access to Testing (ICATT) program will continue no-cost testing for uninsured persons, though there may be a reduction in testing locations after the PHE ends. Individuals can find a no-cost testing location by visiting https://testinglocator.cdc.gov/Search.

    From OSF spokesperson Tim Ditman, "The end of the Public Health Emergency declaration means that most waivers enacted during the pandemic which allowed flexibilities in providing and billing for services also end. The main exception is telehealth services for Medicare enrollees. Those waivers have been extended until the end of calendar year 2024, so services and billing for telehealth services for Medicare enrollees will not change. We will be making necessary adjustments in other areas. Find more information at osfhealthcare.org."

    SHIELD Illinois testing at the University of Illinois’ Campus Recreation Center East (CRCE) will close on May 26, with the option to relocate to another location until June 30. Additional information will be provided if announced.

    Additionally, the CDC has stated there will be reduced reporting of negative laboratory tests for SARS-CoV-2. The change will impact the percent positivity metric used for transmission level reporting. Transmission levels have been used in healthcare settings to determine prevention measures and mitigation strategies. Champaign-Urbana Public Health will continue to report transmission levels for as long as the data is available. The CDC is currently determining how to address healthcare guidance without the use of transmission levels.

    The Champaign-Urbana Public Health District would like to remind residents of steps they can take after the PHE ends to protect themselves and the community:

  • Stay up to date with COVID-19 vaccines and boosters. The FDA has recently authorized the bivalent booster for all doses starting at six months of age, as well as a second bivalent booster for individuals aged 65 and older who have had their primary vaccination series and are at least four months out from a previous bivalent booster shot.
  • Immunocompromised individuals may receive a single additional dose of a bivalent COVID-19 vaccine at least two months following a dose of a bivalent vaccine. Additional doses may be administered at the discretion of, and at intervals determined by, their healthcare provider. Those who might qualify should reach out to their medical provider for further discussion.
  • The monovalent Moderna and Pfizer-BioNTech COVID-19 vaccines are no longer authorized for use in the United States.
  • Alternatives to mRNA vaccines (Novavax or Johnson & Johnson’s Janssen) remain available for individuals who cannot or will not receive an mRNA vaccine.
  • If a person tests positive for COVID-19 after May 11, they should not delay treatment. Staying home when sick, frequent hand washing, mask-wearing, and social distancing are still the most effective ways to keep COVID-19 transmission low.
  • Administrator Julie Pryde says, "The public health emergency declaration is ending, but COVID is still out there making people sick and taking lives. Please stay current on vaccinations. If you develop symptoms of COVID, local healthcare providers can test for COVID, influenza, and RSV at the same visit. Determining which virus you have can help get treatment early when it is most effective."

    Health experts say it is okay to get your flu and COVID shots at the same time

    Lee Batsakis
    OSF Healthcare

    EVERGREEN PARK -- It happens every year: flu season, which typically peaks between December and February. This year will mark the third flu season with another virus also circulating: COVID-19. With an updated safe and effective COVID-19 booster shot now available, health experts are urging people to get both the flu and COVID vaccines in order to protect themselves this fall and winter.

    Doctors recommend patients get both their flu and Covid booster by the end of this month for maximum protection against the two viruses.
    Photo: CDC/Upslash

    Since 2010, the Centers for Disease Control and Prevention (CDC) has recommended annual flu vaccines for everyone six months and older, with few exceptions. New this year is an added recommendation for a higher dose for those 65 and older. The CDC has also recommended the use of updated COVID-19 boosters from Pfizer-BioNTech for people ages 12 years and older and from Moderna for people ages 18 years and older.

    If you have not yet received your COVID-19 booster shot, or if you still have yet to receive an initial dose, it’s not too late.

    "I urge everybody who is eligible to get a COVID booster to do so, and the reasons why are multifactorial. Number one is because your immunity wanes and you need to protect yourself. Number two is that the virus has changed slightly and the newest booster is most effective at protecting against those changes, " says Dr. Bill Walsh, an OSF HealthCare chief medical officer.

    Dr. Walsh adds that it is important to get the seasonal flu shot as well as a COVID shot because they protect against different viruses.

    "Please understand that the recommendation is for both the flu shot and the COVID shot. There is no cross reactivity even though the symptoms might be similar between COVID-19 and influenza. The influenza shot will not help against COVID, and the COVID vaccination will not protect you against influenza, " Dr. Walsh explains.

    The timing of when to get your flu shot and COVID booster can be confusing. The CDC says if you haven’t yet gotten your initial recommended dose of the COVID-19 vaccine, to get one as soon as you can. Health experts typically recommend getting your seasonal flu vaccine by the end of October for best protection during the peak of flu season, and say it is safe to get both vaccines during the same visit.

    "There are many times when you get more than one vaccine. Most of the time when you get a tetanus shot, it also includes pertussis. Many of the vaccinations pediatricians give to children have more than one vaccine in each shot. So, it is standard and normal for more than one vaccine to occur at a time, " Dr. Walsh says.

    Dr. Walsh adds getting both shots done at once alleviates having to make multiple trips to your doctor’s office or local pharmacy. But this route may not be for everyone.

    As with all vaccinations, there are mild side effects that both vaccines can cause, such as joint or muscle pain, fatigue, and chills. If you have experienced side effects from vaccines in the past and it took a couple days for them to subside, you may opt to get the vaccines at separate times.

    "You know yourself best. If you are certain that you will get them both despite not getting them at one appointment, then that is completely fine, too. You may want to space them out because sometimes you have side effects. There have been a lot of questions about whether to get them both in one arm or in different arms so you have different injection sites. That really boils down to personal preference, " advises Dr. Walsh.

    The important thing is making sure you do get both of these vaccinations to protect both yourself and your loved ones. Because the holiday season is approaching, you may have holiday gatherings on your calendar over the next few months. If you get your flu shot in October but choose to wait to get your COVID-19 booster at a later date, Dr. Walsh recommends getting it at least two weeks before any large gatherings in order to ensure the best protection against the virus.

    To schedule your seasonal flu vaccine and COVID-19 booster, make an appointment with your primary care provider or local pharmacy. Talk to your primary care provider if you have any questions about either vaccine.

    Two weeks of executive orders issued by Illinois Gov. J.B. Pritzker in response to the Coronavirus pandemic


    By Joe Tabor, Illinois Policy


    In the last two weeks, Gov. J.B. Pritzker has issued a series of executive orders in response to the spread of the COVID-19 virus in Illinois.

    These executive orders have limited the size of public gatherings, suspended enforcement of certain laws and agency operations, and closed schools and nonessential businesses in an effort to slow the spread of the virus and prevent the state’s health care system from being inundated with severely ill patients. The governors of New York, California, and Ohio have issued similar executive orders.

    But where do those executive powers come from? And what is or isn’t allowed?

    While the federal government is a government of enumerated powers – it can only exercise the powers specifically granted to it by the U.S. Constitution – state governments retain what is known as “police powers” to protect the welfare, safety and health of their residents, in keeping with the 10th Amendment of the U.S. Constitution.

    This system means that states have more flexibility to act without running up against constitutional barriers. It also means states, not the federal government, have the power to tighten or loosen the restrictions ordered by state governors.

    The governor’s authority to issue the recent series of COVID-19 executive orders comes from Section 7 of the Illinois Emergency Management Agency Act. In the case of a disaster such as a viral epidemic, the governor can issue a proclamation declaring that disaster, allowing him to exercise the emergency powers authorized in the act for a period of up to 30 days. State and local police can work together to enforce orders given under these emergency powers.

    Pritzker declared a statewide disaster on March 9, triggering his emergency powers. He began issuing a series of executive orders a few days later.

    Pritzker’s emergency powers include but are not limited to the following, which have been cited in the governor’s orders thus far:

  • To suspend any provisions of regulatory statute that would prevent, hinder or delay necessary action by the state or state agencies.
  • To utilize all available resources of the state government reasonably necessary to cope with the disaster.
  • To redirect state departments or agencies toward disaster response purposes.
  • To control the movement of persons and occupancy of premises within the disaster area.
  • To provide temporary emergency housing.
  • To control, restrict, and regulate the use, sale, or distribution of food, feed, fuel, clothing and other commodities, materials, goods, or services.

    Pritzker is not the first Illinois governor to invoke the Emergency Management Agency Act. For example, former Gov. George Ryan twice made use of the provisions of Section 9 that allowed him to transfer money to the Illinois Emergency Management Agency after a tornado hit Centralia, Illinois, in 2002.

    Here is a timeline of Pritzker’s executive orders so far:

    March 12:
    COVID-19 Executive Order No. 1:

  • Extends the application deadlines for cannabis growers, infusers, and transporters to March 30, 2020


    March 13:
    COVID-19 Executive Order No. 2:

  • Cancels all public and private gatherings of 1,000 people or more
  • Closes the Thompson Center to the general public
  • Suspends the two-year continuous service requirement for state employees to receive advancement of sick leave

    COVID-19 Executive Order No. 3:

  • Closes all public and private K-12 schools through March 30
  • Suspends definition of student “chronic absences” so that it will not include absences due to COVID-19 closures and absences
  • Suspends the requirement that school districts gain approval for the implementation of e-learning programs


    March 15:
    COVID-19 Executive Order No. 4:

  • Clarifies that the closure of schools does not close the buildings for food provision or noneducational purposes like polling places


    March 16:
    COVID-19 Executive Order No. 5:

  • All bars and restaurants must cease all on-premises consumption through March 30 (later extended)
  • Prohibits all public and private gatherings of 50 people or more
  • Suspends one-week waiting period for unemployment claims
  • Suspends Open Meetings Act requirement that members of a public body must be physically present. Encourages postponing official government business when possible, and when conducting government business can’t be postponed, making video and phone access available to the public


    March 17:
    COVID-19 Executive Order No. 6:

  • Suspends expiration of vehicle registration, driver’s licenses, parking decals, state ID cards and related proceedings
  • Suspends filing requirements for statements of economic interest by certain public officials and state employees under governmental ethics laws


    March 19:
    COVID-19 Executive Order No. 7:

  • Mandates health insurance issuers regulated by the Department of Insurance cover the costs of in-network telehealth services


    March 20:
    COVID-19 Executive Order No. 8:
    Orders residents to stay at home, barring exceptions such as essential travel for essential work or supplies, exercise and recreation, through April 7.

  • Defines essential businesses, operations and government functions that are exempt from the order
  • Reduces allowable public and private gathering size to no more than 10 people
  • Orders all law enforcement officers to cease enforcing eviction orders for residential premises


    March 23:
    COVID-19 Executive Order No. 9:

  • Suspends requirement that Department of Corrections provide relevant state’s attorney’s office 14 days’ notice before an inmate receives an early release for good conduct and replaces with requirement that notice be provided as far in advance as possible or as quickly as possible
  • Makes several minor revisions, clarifications or additions to previous executive orders


    March 24:
    COVID-19 Executive Order No. 10:

  • Suspends prohibition on hiring nursing assistants who are inactive on the Healthcare Worker Registry if they meet certain criteria
  • Extends the conditional employment period for nurse assistants pending fingerprinting/criminal background check
  • Suspends provision requiring 30-day written notice from the Department of Juvenile Justice before a youth inmates target release date and replaces with requirement that the department notify the state’s attorney’s office of release dates with as much advance notice as possible or as quickly as possible
  • Suspends requirement that Miners’ Examining Board hold an exam once every month


    March 26: COVID-19 Executive Order No. 11:

  • Suspends all admissions to the Illinois Department of Corrections from all Illinois county jails, with exceptions at the sole discretion of the Director of the Illinois Department of Corrections for limited essential transfers


    COVID-19 Executive Order No. 12:

  • Allows two-way audio-video communication to satisfy the requirement that a person must “appear” before a Notary Public
  • Allows any act of witnessing required by Illinois law may be completed remotely by via two-way audio-video communication if the communication meets certain requirements
  • Allows all legal documents to be signed in counterparts by witnesses and signatory absent an express prohibition, and sets out specific procedures when the signing requires a Notary Public


    March 27:
    COVID-19 Executive Order No. 13:

  • Suspends requirements on the administration of assessments, school terms, and the calculation of daily pupil attendance
  • Allows ISBE to implement rules regarding remote learning
  • Permits the use of early childhood block grant funding to provide child care for children of employees performing essential work
  • Any bids received by a school district for construction purposes may be communicated and accepted electronically


    March 28:
    COVID-19 Executive Order No. 14:

  • Suspends provisions of the vehicle code regarding repossession of vehicles
  • Allows training for Private Detective, Private Alarm, Private Security, Fingerprinting Vendor, and Locksmith Acts to be completed through online instruction COVID-19 Executive Order No. 15:
  • Further Extends the deadlines for previously extended cannabis-related licenses to April 30
  • Directs Department of Agriculture to accept all craft grower, infuser, and transporter license applications post-marked on or before April 30, 2020 via certified US Mail


    April 1:
    COVID-19 Executive Order No. 16:

  • Extends previous executive orders to last until April 30

    COVID-19 Executive Order No. 17:

  • Directs that elective surgeries be cancelled or postponed
  • Protects health care facilities, professionals, and volunteers from from civil liability for any injury or death alleged, unless caused by gross negligence or willful misconduct


    April 6:
    COVID-19 Executive Order No. 18:

  • Allows a verbal attestation documented by the State constitutes a valid signature for applications for public assistance, rather than requiring an audio recording
  • Allows unsigned applications for public assistance received by mail to be signed by a verbal attestation by telephone

    COVID-19 Executive Order No. 19:

  • Suspends the 14-day limit for inmate furloughs
  • Allows furloughs for medical, psychiatric or psychological purposes


    April 7:
    COVID-19 Executive Order No. 20:

  • Suspends date requirements for township annual meetings
  • Suspends license renewal limits for funeral director and embalmer interns
  • Suspends supervision requirement for funeral director interns when transporting bodies to a cemetery, crematory, or final place of disposition
  • Permits persons in the care of the Illinois Department of Children and Family Services who are 18 or older to remain in their placement
  • Suspends the requirement for healthcare workers that designated students, applicants, and employees must have their fingerprints collected electronically and transmitted to the Illinois Department of State Police within 10 working days, provided that they are transmitted within 30 working days of enrollment in a CNA training program or the start of employment

    Originally published by Illinois Policy on April 9, 2020. Published by permission.


  • More Sentinel Stories



    Photo Galleries


    2025 Illinois Marathon Photo Gallery
    A couple of runners found themselves in the wrong race at this year's Illinois Marathon. Over 60 photos from the race that you should see.

    Photos: Sentinel/Clark Brooks